Page 336 - Haematologica Vol. 109 - July 2024

LETTER TO THE EDITOR
central nervous system in adult patients with acute myeloid leukemia: incidence and impact on outcome. Semin Hematol. 2018;55(4):209-214.
4. Pinkel D, Simone J, Hustu HO, Aur RJ. Nine years’ experience with “total therapy” of childhood acute lymphocytic leukemia. Pediatrics. 1972;50(2):246-251.
5. Williams MT, Yousafzai YM, Elder A, et al. The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts. Blood. 2016;127(16):1998-2006.
6. Poon LM, Hamdi A, Saliba R, et al. Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(7):1059-1064.
7. Bassan R, Barbui T. Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age? Haematologica. 1995;80(1):82-90.
8. Holmes R, Keating MJ, Cork A, et al. A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia
associated with inv(16)(p13q22). Blood. 1985;65(5):1071-1078.
9. Rees JK, Gray RG, Swirsky D, Hayhoe FG. Principal results of the
Medical Research Council’s 8th acute myeloid leukaemia trial.
Lancet. 1986;2(8518):1236-1241.
10. Hamdi A, Mawad R, Bassett R, et al. Central nervous system
relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(11):1767-1771.
11. Mayadev JS, Douglas JG, Storer BE, Appelbaum FR, Storb R. Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement. Int J Radiat Oncol Biol Phys. 2011;80(1):193-198.
12. Oshima K, Kanda Y, Yamashita T, et al. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2008;14(10):1100-1107.
Haematologica | 109 July 2024
2350